Medline Industries has signed an agreement to distribute Hospitech Respiration‘s AG Cuffill, a syringe-like device designed to measure both pressure and volume of airway cuffs in clinical settings, the companies announced today.
The distribution deal, effective October 2, will cover all U.S. healthcare markets, the companies said.
“Working with Hospitech strengthens Medline’s portfolio of respiratory solutions designed to improve care, reduce risk and manage costs,” said Tim Finnigan, respiratory division president at Medline, in a news release. “AG Cuffill allows clinicians to make monitoring cuff pressure a standard of care while reducing the risks and costs associated with pressures above or below the recommended range.”
Measuring and adjusting cuff pressure is critical for patients intubated with a cuffed endotracheal (ET) tube, trach tube, or laryngeal mask airway, according to Kfar Saba, Israel-based Hospitech. Cuff pressures can change rapidly, especially during transport or as patients change position. The AG Cuffill can be used by respiratory and anesthesia providers as well as first responders and home providers to reduce the potential for aspirations from an under-inflated cuff or ischemic injury that can result from over-inflation, the company said.
“The partnership with Medline aligns with Hospitech’s mission to ease and improve the treatment of ventilated patients while improving patient outcomes,” said Hospitech CEO Yoav Venkert. “After becoming a standard-of-care in hundreds of hospitals and EMS teams in the USA, Europe, Asia, and other markets, this new partnership with Medline allows us to further grow our reach and offer every healthcare and homecare provider across the USA access to our intuitive disposable manometer for airway cuff pressure management.”